Method and system for detecting the effects of alzheimer's disease in the human retina
AssigneeCarl Zeiss Meditec AG
InventorsQienyuan Zhou, Michael Sinai, John C. Moore, William Wong
Life of this patent
Estimating the term…
Loading patent…
AssigneeCarl Zeiss Meditec AG
InventorsQienyuan Zhou, Michael Sinai, John C. Moore, William Wong
Estimating the term…
A system for the in vivo detection of the effects of AD in the interior of an eye. A scanning polarimeter, including a residual retardance canceling system and an improved anterior segment retardance compensator, produces an optical analysis signal representing the birefringence of the retinal nerve fiber layer (RNFL) structures of the eye. The birefringence data is more accurate because of compensation for anterior segment birefringence and residual birefringence of optical components, such as, for example, the beam splitters, lenses, scanners and retarders. An electrical analysis signal representing a large (20 by 40 degrees) retardance map is produced and evaluated by an artificial neural network to produce an analysis classification signal representing the contribution of Alzheimer's disease to the birefringence of the retinal layer corresponding to the relationship of the electrical analysis signal to an analysis signal database.
A method for detecting the effects of Alzheimer's disease in the interior of an eye having a pupil, comprising the steps of:
A system for detecting the effects of Alzheimer's disease in the interior of an eye having a pupil, comprising:
Dependencies are inferred from the claim text.